A detailed history of Nebula Research & Development LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 144,832 shares of BHC stock, worth $1.32 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
144,832
Holding current value
$1.32 Million
% of portfolio
0.16%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$6.1 - $10.41 $883,475 - $1.51 Million
144,832 New
144,832 $1.01 Billion
Q4 2023

Feb 14, 2024

SELL
$6.53 - $8.23 $215,091 - $271,087
-32,939 Reduced 63.07%
19,289 $155 Million
Q3 2023

Nov 14, 2023

SELL
$7.69 - $9.71 $199,663 - $252,110
-25,964 Reduced 33.21%
52,228 $429 Million
Q2 2023

Aug 14, 2023

BUY
$5.72 - $8.8 $369,798 - $568,920
64,650 Added 477.4%
78,192 $626 Million
Q1 2023

May 15, 2023

BUY
$6.28 - $9.85 $85,043 - $133,388
13,542 New
13,542 $110 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.3B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.